Skip to main content
Veterinary Medicines

Nalgosed, 10mg/ml, Solution for injection

Authorised
  • Butorphanol

Product identification

Medicine name:
Nalgosed 10mg/ml ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Nalgosed, 10mg/ml, Solution for injection
Active substance:
  • Butorphanol
Target species:
  • Cat
  • Dog
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Butorphanol
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
    • Dog
  • Intravenous use
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cat
    • Dog
  • Subcutaneous use
    • Cat
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AF01
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • Glass Vial 1 x 10.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 74783/04-08-2021/K-0232301
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0142/001
Concerned member states:
  • Bulgaria
  • Estonia
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovakia
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."